Analysts Predict 14% Upside For The Holdings of FYX

The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $115.39, representing a 14.09% upside from its recent trading price of $101.14, based on the weighted average of its underlying holdings' analyst targets. This potential upside is notably influenced by specific holdings, including MiMedx Group Inc (MDXG) with a 76.99% implied upside, Core Scientific Inc (CORZ) at 37.83%, and Klaviyo Inc (KVYO) at 34.46%. While these figures suggest significant growth potential, the analysis implicitly questions the long-term justification of these analyst targets, advising further investor research.

Analysis

Based on a weighted average of its underlying holdings' analyst targets, the First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied 12-month target price of $115.39, representing a 14.09% upside from its recent price of $101.14. This potential is significantly driven by a few key holdings with substantial analyst-projected gains, including MiMedx Group Inc (MDXG) with a 76.99% upside to its $12.00 target, Core Scientific Inc (CORZ) with a 37.83% upside to $18.17, and Klaviyo Inc (KVYO) with a 34.46% upside to $43.70. While these figures indicate strong positive sentiment from analysts on certain small-cap names, the analysis also introduces a necessary note of caution. The significant divergence between current trading prices and analyst targets raises questions about whether these targets are overly optimistic or have lagged recent company-specific or industry developments, suggesting that a high target could be a precursor to future downgrades if the underlying fundamentals do not support the bullish outlook.

Key Decisions for Investors

• Investors interested in small-cap exposure could consider FYX, but must perform due diligence on the top holdings driving the ETF's implied upside, such as MDXG, to validate the high analyst price targets.